Overview

Open Label, Zonegran (Zonisamide) In Partial Onset Seizures

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of adjunctive open label Zonegran treatment in patients with refractory partial seizures.
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Limited
Treatments:
Zonisamide